ARTL
First covered
Mar 18, 2026
Biggest move
+163.32%
at report time
Float, first → latest
~708K → ~300K
Dilution filings, coverage windows
6
S-1 2026-03-20 +5 more
Run history — newest first
RUN 2
Mar 27, 2026 ARTL Stock Surges 163% as Clinical Expansion into $16.3B Glaucoma Market Demonstrates Platform Power +163.32% at report · float ~300K DILUTED D+6 · -55.1%
Mar 27, 2026 ARTL Stock Surges 163% as Clinical Expansion into $16.3B Glaucoma Market Demonstrates Platform Power +163.32% at report · float ~300K DILUTED D+6 · -55.1%
RUN 1
Mar 18, 2026 ARTL Pops 33% on Glaucoma Study Deal, But Don't Ignore the Warning Signs +32.68% at report · float ~708K DILUTED D+2 · -50.4%
Mar 18, 2026 ARTL Pops 33% on Glaucoma Study Deal, But Don't Ignore the Warning Signs +32.68% at report · float ~708K DILUTED D+2 · -50.4%
Float across our coverage — the dilution fingerprint